当前位置: 首页 >> 检索结果
330. Left Atrial Appendage Remodeling After Lariat Left Atrial Appendage Ligation.
作者: Bahij Kreidieh.;Francia Rojas.;Paul Schurmann.;Amish S Dave.;Amir Kashani.;Moisés Rodríguez-Mañero.;Miguel Valderrábano.
来源: Circ Arrhythm Electrophysiol. 2015年8卷6期1351-8页
Left atrial appendage (LAA) ligation with the Lariat device is being used for stroke prevention in atrial fibrillation. Residual leaks into the LAA are commonly reported after the procedure. Little is known about the anatomic LAA remodeling after Lariat ligation.
331. Long-Term Suppression of Atrial Fibrillation by Botulinum Toxin Injection Into Epicardial Fat Pads in Patients Undergoing Cardiac Surgery: One-Year Follow-Up of a Randomized Pilot Study.
作者: Evgeny Pokushalov.;Boris Kozlov.;Alexander Romanov.;Artem Strelnikov.;Sevda Bayramova.;David Sergeevichev.;Alexander Bogachev-Prokophiev.;Sergey Zheleznev.;Vladimir Shipulin.;Vladimir V Lomivorotov.;Alexander Karaskov.;Sunny S Po.;Jonathan S Steinberg.
来源: Circ Arrhythm Electrophysiol. 2015年8卷6期1334-41页
Animal models suggest that the neurotransmitter inhibitor, botulinum toxin, when injected into the epicardial fat pads can suppress atrial fibrillation inducibility. The aim of this prospective randomized double-blind study was to compare the efficacy and safety of botulinum toxin injection into epicardial fat pads for preventing atrial tachyarrhythmias.
332. Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization: A Report From the NCDR IMPACT Registry.
作者: Natalie Jayaram.;Robert H Beekman.;Lee Benson.;Ralf Holzer.;Kathy Jenkins.;Kevin F Kennedy.;Gerard R Martin.;John W Moore.;Richard Ringel.;Jonathan Rome.;John A Spertus.;Robert Vincent.;Lisa Bergersen.
来源: Circulation. 2015年132卷20期1863-70页
As US health care increasingly focuses on outcomes as a means for quantifying quality, there is a growing demand for risk models that can account for the variability of patients treated at different hospitals so that equitable comparisons between institutions can be made. We sought to apply aspects of prior risk-standardization methodology to begin development of a risk-standardization tool for the National Cardiovascular Data Registry (NCDR) IMPACT (Improving Pediatric and Adult Congenital Treatment) Registry.
335. Robotic Mitral Valve Repair for Simple and Complex Degenerative Disease: Midterm Clinical and Echocardiographic Quality Outcomes.
作者: Rakesh M Suri.;Amit Taggarse.;Harold M Burkhart.;Richard C Daly.;William Mauermann.;Rick A Nishimura.;Zhuo Li.;Joseph A Dearani.;Hector I Michelena.;Maurice Enriquez-Sarano.
来源: Circulation. 2015年132卷21期1961-8页
Severe primary (degenerative) mitral regurgitation (MR) is repaired with durable results when simple single-scallop disease is addressed. The midterm quality outcomes of minimally invasive repair for complex disease are unknown, however.
339. Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease".
作者: Ann Marie Navar-Boggan.;Eric D Peterson.;Ralph B D'Agostino.;Benjamin Neely.;Allan D Sniderman.;Michael J Pencina.
来源: Circulation. 2015年132卷16期e203页 |